Tekla Capital Management Lifted Sarepta Therapeutics (SRPT) Holding; Ajo LP Lowered By $61.20 Million Its Tyson Foods (A) (TSN) Position

January 22, 2018 - By Richard Conner

Ajo Lp decreased Tyson Foods (A) (TSN) stake by 86.38% reported in 2017Q3 SEC filing. Ajo Lp sold 874,343 shares as Tyson Foods (A) (TSN)’s stock declined 10.27%. The Ajo Lp holds 137,817 shares with $9.71 million value, down from 1.01M last quarter. Tyson Foods (A) now has $30.21 billion valuation. The stock increased 0.46% or $0.37 during the last trading session, reaching $80.56. About 656,639 shares traded. Tyson Foods, Inc. (NYSE:TSN) has declined 9.94% since January 22, 2017 and is downtrending. It has underperformed by 26.64% the S&P500.

Tekla Capital Management Llc increased Sarepta Therapeutics Inc. (SRPT) stake by 4.89% reported in 2017Q3 SEC filing. Tekla Capital Management Llc acquired 25,000 shares as Sarepta Therapeutics Inc. (SRPT)’s stock rose 22.49%. The Tekla Capital Management Llc holds 536,600 shares with $24.34M value, up from 511,600 last quarter. Sarepta Therapeutics Inc. now has $4.23B valuation. The stock increased 5.02% or $3.13 during the last trading session, reaching $65.51. About 1.33M shares traded. Sarepta Therapeutics, Inc. (NASDAQ:SRPT) has risen 96.82% since January 22, 2017 and is uptrending. It has outperformed by 80.12% the S&P500.

Tekla Capital Management Llc decreased Tenet Healthcare Corporation (NYSE:THC) stake by 148,940 shares to 164,500 valued at $2.70M in 2017Q3. It also reduced Adaptimmune Therapeutics Plc stake by 531,000 shares and now owns 935,368 shares. Novo Nordisk A/S (NYSE:NVO) was reduced too.

Since October 3, 2017, it had 0 insider buys, and 1 insider sale for $575,000 activity. Ruff Shamim had sold 11,500 shares worth $575,000.

Investors sentiment increased to 2.88 in Q3 2017. Its up 1.36, from 1.52 in 2017Q2. It is positive, as 24 investors sold SRPT shares while 27 reduced holdings. 63 funds opened positions while 84 raised stakes. 51.70 million shares or 25.22% more from 41.29 million shares in 2017Q2 were reported. American Century Cos holds 0% of its portfolio in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) for 72,394 shares. Cornerstone Cap Mgmt Ltd Co holds 25,894 shares. Commonwealth Equity Incorporated holds 0% or 7,714 shares in its portfolio. Cubist Systematic Strategies Ltd Co owns 1,786 shares for 0% of their portfolio. Tiaa Cref Investment Mngmt Limited Liability Company reported 0.01% of its portfolio in Sarepta Therapeutics, Inc. (NASDAQ:SRPT). Lehman Financial Resource holds 0.15% or 6,392 shares. Sit Invest Associates Incorporated holds 0.04% or 33,225 shares. Trexquant LP reported 8,846 shares. Great Point Partners Limited Liability Company invested in 2.21% or 250,000 shares. Nationwide Fund Advsrs holds 0.01% in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) or 32,906 shares. Quantbot Techs Lp accumulated 819 shares or 0% of the stock. Rock Springs Capital Mgmt Lp, Maryland-based fund reported 259,200 shares. Columbus Circle Invsts holds 121,758 shares. Barclays Public Limited Co stated it has 279,142 shares or 0.01% of all its holdings. Sphera Funds Mgmt Limited accumulated 384,997 shares or 2.49% of the stock.

Among 27 analysts covering Sarepta Therapeutics (NASDAQ:SRPT), 21 have Buy rating, 0 Sell and 6 Hold. Therefore 78% are positive. Sarepta Therapeutics had 97 analyst reports since August 5, 2015 according to SRatingsIntel. Roth Capital maintained Sarepta Therapeutics, Inc. (NASDAQ:SRPT) on Wednesday, August 26 with “Buy” rating. On Thursday, August 20 the stock rating was maintained by Roth Capital with “Buy”. Cowen & Co upgraded Sarepta Therapeutics, Inc. (NASDAQ:SRPT) on Tuesday, September 20 to “Outperform” rating. The stock has “Buy” rating by RBC Capital Markets on Wednesday, June 21. Janney Capital initiated Sarepta Therapeutics, Inc. (NASDAQ:SRPT) on Wednesday, April 20 with “Neutral” rating. SunTrust downgraded the shares of SRPT in report on Friday, August 7 to “” rating. Needham maintained Sarepta Therapeutics, Inc. (NASDAQ:SRPT) rating on Tuesday, September 20. Needham has “Buy” rating and $81 target. The firm has “Buy” rating given on Wednesday, August 26 by William Blair. The firm earned “Overweight” rating on Thursday, December 22 by JP Morgan. The firm has “Outperform” rating by Leerink Swann given on Thursday, March 2.

Investors sentiment increased to 1.09 in 2017 Q3. Its up 0.09, from 1 in 2017Q2. It is positive, as 42 investors sold TSN shares while 195 reduced holdings. 68 funds opened positions while 191 raised stakes. 250.18 million shares or 0.40% less from 251.19 million shares in 2017Q2 were reported. Credit Agricole S A holds 0.11% or 440,916 shares. Hillsdale Mngmt accumulated 4,200 shares. 132,437 were accumulated by Sterling Cap Ltd Llc. Orrstown Financial Service owns 70 shares for 0.01% of their portfolio. Da Davidson invested in 0.01% or 6,461 shares. U S Inc has 0.22% invested in Tyson Foods, Inc. (NYSE:TSN) for 8,500 shares. Texas Permanent School Fund holds 80,165 shares or 0.07% of its portfolio. Montecito Natl Bank Tru holds 0.12% or 4,925 shares. 312,200 are owned by Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Investment Mngmt. Balyasny Asset Management Ltd Co owns 1.20M shares. Ing Groep Nv accumulated 24,999 shares. Commerzbank Aktiengesellschaft Fi reported 148,719 shares. Peddock Advsr Ltd Liability holds 0.44% or 12,250 shares in its portfolio. The United Kingdom-based Hsbc Public Limited has invested 0.06% in Tyson Foods, Inc. (NYSE:TSN). Amp owns 0.09% invested in Tyson Foods, Inc. (NYSE:TSN) for 230,737 shares.

Among 15 analysts covering Tyson Foods Inc. (NYSE:TSN), 9 have Buy rating, 0 Sell and 6 Hold. Therefore 60% are positive. Tyson Foods Inc. had 55 analyst reports since August 5, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Thursday, April 21 by Argus Research. CLSA maintained the shares of TSN in report on Tuesday, August 2 with “Outperform” rating. The firm has “Neutral” rating given on Tuesday, November 24 by Credit Suisse. The company was maintained on Thursday, December 21 by RBC Capital Markets. The rating was maintained by Jefferies on Wednesday, August 30 with “Buy”. The firm has “Hold” rating given on Tuesday, November 14 by RBC Capital Markets. The stock of Tyson Foods, Inc. (NYSE:TSN) has “Hold” rating given on Monday, November 13 by Pivotal Research. The company was maintained on Monday, August 7 by BMO Capital Markets. The stock of Tyson Foods, Inc. (NYSE:TSN) has “Outperform” rating given on Tuesday, November 24 by RBC Capital Markets. On Monday, October 2 the stock rating was maintained by Barclays Capital with “Overweight”.

Since November 28, 2017, it had 0 insider buys, and 1 insider sale for $4.40 million activity. Hayes Thomas P had sold 53,874 shares worth $4.40 million on Tuesday, November 28.

Ajo Lp increased Lilly (Eli) & Co (NYSE:LLY) stake by 41,324 shares to 1.74M valued at $148.98M in 2017Q3. It also upped Mercer Intl (NASDAQ:MERC) stake by 66,679 shares and now owns 514,669 shares. Globus Medical (NYSE:GMED) was raised too.

Analysts await Tyson Foods, Inc. (NYSE:TSN) to report earnings on February, 5. They expect $1.53 earnings per share, down 3.77% or $0.06 from last year’s $1.59 per share. TSN’s profit will be $573.73 million for 13.16 P/E if the $1.53 EPS becomes a reality. After $1.43 actual earnings per share reported by Tyson Foods, Inc. for the previous quarter, Wall Street now forecasts 6.99% EPS growth.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>